Seasoned Global Clinical Development Leader

MD with 20+ years of experience in the biopharma industry leading multi-functional teams to drive key Clinical Development strategies.

Will strategically drive your novel therapies through generation of development plans, trial design, implementation, execution, and analysis of clinical studies. Has decades worth of experience successfully leading global teams and acting as a mentor to translational teams.

Relevant Therapeutic Areas

  • CNS: Parkinson’s Disease
  • Inflammation: Pseudomembranous colitis, inflammatory bowel diseases, gout
  • Rare Diseases: Fibrodysplasia ossificans progressiva, Achondroplasia, Fasciculo-scapulo-humeral Muscular Dystrophy
  • Cardiovascular Diseases: Congestive Heart Failure (hANP), QTc prolongation for a variety of medications, Cardiac transplantation (Neoral, Galenya, Myfortic)

Product Technologies

  • Gene Therapies
  • Monoclonal Antibodies
  • Immunotherapies
  • Biologics
  • Small Molecules
  • Vaccines

Recent Titles

  • Vice President, Clinical Development
  • Senior Director, Clinical Research


  • Greater New York Area
  • Open to remote and in-office

Relevant Companies

  • Daiichi
  • Novartis
  • Schering Plough
  • Small Biotechs

Skills & Accomplishments

  • Participated in 7 NDAs, 3 sNDAs, and more than 10 INDs.
  • Clinical trial physician on studies conducted in US, Europe, Japan, Latin America and South Africa.
  • Accountable for recruiting of investigators, authoring of clinical sections of key documents, as well as providing scientific and medical expertise to the development team